Marconi puts ailing medical business up for sale
This article was originally published in Clinica
Marconi Medical, the former Picker International imaging business, which has been running behind the big four imaging companies and has been losing share in Europe, is to be sold.
You may also be interested in...
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
The first of around 260 patients for a clinical trial comparing its PB006 natalizumab biosimilar candidate to Biogen’s Tysabri reference brand have been recruited by Polpharma Biologics, which has just added Karsten Roth and Alexandra Moulson to its team.